Ra Capital Management, L.P. Verona Pharma PLC Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Ra Capital Management, L.P. holds 5,009,653 shares of VRNA stock, worth $269 Million. This represents 2.01% of its overall portfolio holdings.
Number of Shares
5,009,653
Previous 7,632,646
34.37%
Holding current value
$269 Million
Previous $110 Million
30.59%
% of portfolio
2.01%
Previous 1.66%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
168Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$339 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$300 Million12.27% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$226 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$190 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$182 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.27B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...